Surgical Gastroenterology Unit, Division of General Surgery, Department of Surgery, Faculty of Health Sciences, Groote SchuurHospital, University of Cape Town, South Africa.
Surgical Gastroenterology Unit, Division of General Surgery, Department of Surgery, Faculty of Health Sciences, Groote Schuur Hospital, University of Cape Town, South Africa.
S Afr J Surg. 2024 May;62(2):39-43.
BACKGROUND: Surgical resection of distal cholangiocarcinoma (dCCA) offers the only chance for cure and long-term survival. The current literature provides limited data regarding the surgical management and long-term outcomes of dCCA. This study aims to describe the presentation, management, and outcomes of dCCA at a large academic referral centre in South Africa. METHODS: A retrospective study was performed of all patients who underwent curative-intended surgery for dCCA at Groote Schuur Hospital from 2000 to 2020. RESULTS: Over 21 years, 25 patients underwent pancreaticoduodenectomy (PD) for dCCA. Most patients were male (68%), and the mean age was 56.8 years. Of the patients, 22 (84%) underwent preoperative biliary drainage (PBD). There were 29 recorded complications in 25 patients; postoperative pancreatic fistula (POPF) and surgical site infection (SSI) each occurred in 24% of the cohort. The mean hospital stay was 17.2 days without perioperative mortality. With none lost to follow-up, the 1, 3, 5, 10, and 20-year survival rates were 84%, 24%, 16%, 12%, and 4%, respectively. Only T3 status was associated with significantly lower overall survival (OS). Age, albumin levels, PBD, margin status (R0 vs. R1), and nodal status (N0 vs. N1/N2) did not influence OS. CONCLUSION: This is the first study detailing the management and outcomes of dCCA from sub-Saharan Africa (SSA). Despite the complete resection of dCCA, the prognosis is poor, and the long-term survival rate in our study is equivalent to that reported in the literature. T3 disease is an important prognostic factor and is associated with poor OS. Surprisingly, nodal disease and margin status did not affect OS in the cohort of patients.
背景:远端胆管癌(dCCA)的手术切除是唯一能治愈和长期生存的机会。目前的文献提供了有限的数据,关于 dCCA 的手术治疗和长期结果。本研究旨在描述南非一家大型学术转诊中心的 dCCA 的表现、治疗和结果。
方法:对格罗特舒尔医院 2000 年至 2020 年期间接受根治性手术治疗的所有 dCCA 患者进行回顾性研究。
结果:21 年来,25 例患者接受胰十二指肠切除术(PD)治疗 dCCA。大多数患者为男性(68%),平均年龄为 56.8 岁。22 例(84%)患者接受术前胆道引流(PBD)。25 例患者中有 29 例记录的并发症;术后胰瘘(POPF)和手术部位感染(SSI)分别发生在该队列的 24%。平均住院时间为 17.2 天,无围手术期死亡。无失访患者,1、3、5、10 和 20 年生存率分别为 84%、24%、16%、12%和 4%。只有 T3 状态与总生存率(OS)显著降低相关。年龄、白蛋白水平、PBD、切缘状态(R0 与 R1)和淋巴结状态(N0 与 N1/N2)均不影响 OS。
结论:这是第一份详细描述来自撒哈拉以南非洲(SSA)的 dCCA 管理和结果的研究。尽管完全切除了 dCCA,但预后仍然很差,我们的研究中长期生存率与文献报道相当。T3 疾病是一个重要的预后因素,与 OS 不良相关。令人惊讶的是,淋巴结疾病和切缘状态在患者队列中均不影响 OS。
S Afr J Surg. 2024-5
Hepatobiliary Pancreat Dis Int. 2020-4
World J Gastroenterol. 2014-6-7